Lv41
659 积分 2022-12-04 加入
Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using 177Lu-, 90Y-, and 225Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies
1小时前
求助中
Particle radiotherapy in the era of radioimmunotherapy
3个月前
已完结
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
4个月前
已完结
Efficacy, Safety, Blood Kinetics, and213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients
4个月前
已完结
Designing nanozymes for in vivo applications
8个月前
已完结
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy
8个月前
已完结
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer
8个月前
已完结
Efficacy, Safety, Blood Kinetics, and213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients
9个月前
已完结
The Future of Follicular Lymphoma Management: Strategies on the Horizon
9个月前
已完结
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
9个月前
已完结
皖公网安备34019202002308
